Back to Search Start Over

OC-0280 ReRT with bevacizumab is related to lower rate of radionecrosis as reRT alone for recurrent glioma.

Authors :
Fleischmann, D.
Jenn, J.
Corradini, S.
Ruf, V.
Forbrig, R.
Unterrainer, M.
Thon, N.
Kreth, F.W.
Belka, C.
Niyazi, M.
Source :
Radiotherapy & Oncology. 2019 Supplement 1, Vol. 133, pS138-S139. 2p.
Publication Year :
2019

Subjects

Subjects :
*BEVACIZUMAB
*RATES

Details

Language :
English
ISSN :
01678140
Volume :
133
Database :
Academic Search Index
Journal :
Radiotherapy & Oncology
Publication Type :
Academic Journal
Accession number :
136562345
Full Text :
https://doi.org/10.1016/S0167-8140(19)30700-5
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details